• Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
    • Recruiting and informing the potential subject.
    • Research with minors and incapacitated subjects
    • The role of the treating physician and investigator
  • Documents
  • Information & Contact
    • METc – bureau
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2021
    • Brexit and possible consequences for clinical research
    • Clinical Trial Regulation expected to apply from December 2021
    • New template Subject Information Sheet is mandatory from November 2020.
    • CCMO will be the competent authority for clinical investigations with medical devices
    • Modified procedure for submitting local feasibility declaration
    • What is the impact of the GDPR on the informed consent letter?
    • Conditions for (re)starting clinical research in healthcare institutions and CRUs aligned
  • English
    • Dutch
Menu
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
    • Recruiting and informing the potential subject.
    • Research with minors and incapacitated subjects
    • The role of the treating physician and investigator
  • Documents
  • Information & Contact
    • METc – bureau
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2021
    • Brexit and possible consequences for clinical research
    • Clinical Trial Regulation expected to apply from December 2021
    • New template Subject Information Sheet is mandatory from November 2020.
    • CCMO will be the competent authority for clinical investigations with medical devices
    • Modified procedure for submitting local feasibility declaration
    • What is the impact of the GDPR on the informed consent letter?
    • Conditions for (re)starting clinical research in healthcare institutions and CRUs aligned
  • English
    • Dutch
Search
Close

Conditions for (re)starting clinical research in healthcare institutions and CRUs aligned

As of 25 August 2020, the conditions for (re)starting clinical research in clinical research units (CRUs) are the same as those for healthcare institutions. This has been decided by the Health Care and Youth Inspectorate (IGJ) together with CCMO.

See the original news item on the website of the CCMO: link

Print or export to pdf
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact
Menu
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact

POWERED BY Wild Sea 2020